follow us:Google+ FacebookLinkedInTwitterRSS Feeds


Celsion announces $15M direct offering


Back to Top Comments Email Print

Latest News


Lawrenceville-based biopharmaceutical company Celsion Corporation announced Wednesday that it has received commitments from investors to purchase approximately $15 million in common stock in an at-the-market registered direct offering led by a dedicated health care fund.

According to the announcement, Celsion entered into definitive purchase agreements with the investors to sell 3.6 million shares of common stock at a per-share price of $4.16. The closing of the offering is expected to take place around January 21.

The estimated net profit to the company from the offering are expected to be approximately $13.8 million. The announcement said H.C. Wainwright & Co., LLC acted as exclusive placement agent in connection with the offering, Celsion said in a statement.

Like us on Facebook:

Share This Story On:
Emily Bader

Emily Bader

Emily Bader is the copy and web editor at NJBIZ. She is a Brielle, N.J. native and a Rutgers University alum. You can contact her at or @emilybader on Twitter.



Be the first to comment.

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
Back to Top